Skip to content

A clinical trial to study the comparative effects of two drugs dexmetedetomidine or fentanyl when added to ropivacaine for regional abdominal block

Evaluation of analgesic efficacy of dexmetedetomidine or fentanyl as adjuvant to ropivacaine for USG guided transversus abdominus plane block(TAP) in abdominal Surgeries. - RACE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059384
Enrollment
90
Registered
2023-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K352- Acute appendicitis with generalized peritonitis Health Condition 2: K420- Umbilical hernia with obstruction,without gangrene

Interventions

Intervention1: Fentalnyl: Fentalnyl 1mcg/kg add with 20ml of ropivacaine 0.25 % Control Intervention1: Dexmedetomidine: Dexmedetomidine 1mcg/kg add with 20ml of ropivacaine 0.25 %.

Sponsors

Gandhi Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. After obtaining approval from institutional Ethics Committee and informed written consent will be taken from all patients. 2. Patients of ASA grade 1&2. 3. Age group between16-50 years of both sex. 4. All patients undergoing for abdominal surgeries.

Exclusion criteria

Exclusion criteria: 1. Patients refusal or not giving consent. 2. Patients with history of cardiac, respiratory, renal or hepatic failure. 3. Psychological disorders, local skin infections or disease

Design outcomes

Primary

MeasureTime frame
To observe intra operative and post operative opioid requirement and additional analgesic requirements. To observe the duration of analgesia in all 3 groups. To observe adverse events if any for 2 hoursTimepoint: To observe intra operative and post operative opioid requirement and additional analgesic requirements. To observe the duration of analgesia in all 3 groups. To observe adverse events if any for 2 hours

Secondary

MeasureTime frame
To assess the hemodynamic parameters & any complications for 2 hoursTimepoint: To assess the hemodynamic parameters & any complications for 2 hours

Countries

India

Contacts

Public ContactDr Sonal Awasya

Gandhi Medical College Bhopal

awasya.84@gmail.com8435725830

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026